Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan 27:108:577-585.
doi: 10.1016/j.ejmech.2015.12.014. Epub 2015 Dec 13.

Development of sigma-1 (σ1) receptor fluorescent ligands as versatile tools to study σ1 receptors

Carmen Abate  1 , Chiara Riganti  2 , Maria Laura Pati  3 , Dario Ghigo  2 , Francesco Berardi  3 , Timur Mavlyutov  4 , Lian-Wang Guo  4 , Arnold Ruoho  5
Affiliations

Development of sigma-1 (σ1) receptor fluorescent ligands as versatile tools to study σ1 receptors

Carmen Abate et al. Eur J Med Chem. .

Abstract

Despite their controversial physiology, sigma-1 (σ1) receptors are intriguing targets for the development of therapeutic agents for central nervous system diseases. With the aim of providing versatile pharmacological tools to study σ1 receptors, we developed three σ1 fluorescent tracers by functionalizing three well characterized σ1 ligands with a fluorescent tag. A good compromise between σ1 binding affinity and fluorescent properties was reached, and the σ1 specific targeting of the novel tracers was demonstrated by confocal microscopy and flow cytometry. These novel ligands were also successfully used in competition binding studies by flow cytometry, showing their utility in nonradioactive binding assays as an alternative strategy to the more classical radioligand binding assays. To the best of our knowledge these are the first σ1 fluorescent ligands to be developed and successfully employed in living cells, representing promising tools to strengthen σ1 receptors related studies.

Keywords: Fluorescent ligand; Sigma receptors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
σ1 Receptor lead compounds exploited for the development of σ1 fluorescent ligands.
Fig. 2
Fig. 2. Labeling of ARPE19 Cells with compound 9
Signal is localized to intracellular membranes. Lower intensity of labeling is detected when cells were prelabeled with PB190 100 µM. Scale bar = 20 µm.
Fig. 3
Fig. 3
Flow Cytometry analysis (cell associated fluorescence vs cell count) of MCF7σ1 and MCF7wt, exposed to compound 5 or 6 and treated with compound 10 (10 µM) to mask σ2 receptors, or (+)-pentazocine (10 µM) to mask σ1 receptors, or both 10 (10 µM) with (+)-pentazocine (10 µM). A) Displacement of 5 (100 nM, yellow curve): black curve: control; red curve: 10 µM 10; green curve: 10 µM (+)-pentazocine; violet curve: 10 µM 10 with (+)-pentazocine 10 µM. B) Displacement of 6 (100 nM, yellow curve): black curve: control; red curve: 10 µM 10; green curve: 10 µM (+)-pentazocine; violet curve: 10 µM 10 with (+)-pentazocine 10 µM.
Fig. 4
Fig. 4
Flow Cytometry analysis (cell associated fluorescence vs cell count) of MCF7σ1 and MCF7wt, exposed to 5 and treated with 10 (10 µM) to mask σ2 receptors. A) Displacement of 5 (100 nM, yellow curve) with increasing concentrations of PB190: black curve: control; orange curve: 1 nM PB190; red curve: 10 nM PB190; green curve: 100 nM PB190; blue curve: 1 µM PB190; violet curve: 10 µM PB190. B) Displacement of 5 (100 nM, yellow curve) with increasing concentrations of PB212: black curve: control; orange curve: 1 nM PB212; red curve: 10 nM PB212; green curve: 100 nM PB212; blue curve: 1 µM PB212; violet curve: 10 µM PB212.
Fig. 5
Fig. 5
Flow cytometry analysis (cell associated fluorescence vs cell count) of MCF7σ1 and MCF7wt, exposed to 6 and treated with 10 (10 µM) to mask σ2 receptors. A) Displacement of 6 (100 nM, yellow curve) with increasing concentrations of PB190: black curve: control; orange curve: 1 nM PB190; red curve: 10 nM PB190; green curve: 100 nM PB190; blue curve: 1 µM PB190; violet curve: 10 µM PB190. B) Displacement of 6 (100 nM, yellow curve) with increasing concentrations of PB212: black curve: control; orange curve: 1 nM PB212; red curve: 10 nM PB212; green curve: 100 nM PB212; blue curve: 1 µM PB212; violet curve: 10 µM PB212.
Fig. 6
Fig. 6
Flow cytometry analysis (cell associated fluorescence vs cell count) of MCF7σ1 and MCF7wt, exposed to 5 or 6 and treated with 10 (10 µM) to mask σ2 receptors. A) Displacement of 5 (100 nM, yellow curve) with increasing concentrations of (+)-pentazocine: black curve: control; orange curve: 1 nM (+)-pentazocine; red curve: 10 nM (+)-pentazocine; green curve: 100 nM (+)-pentazocine; blue curve: 1 µM (+)-pentazocine; violet curve: 10 µM (+)-pentazocine. B) Displacement of 6 (100 nM, yellow curve) with increasing concentrations of (+)-pentazocine: black curve: control; orange curve: 1 nM (+)-pentazocine; red curve: 10 nM (+)-pentazocine; green curve: 100 nM (+)-pentazocine; blue curve: 1 µM (+)-pentazocine; violet curve: 10 µM (+)-pentazocine.
Scheme 1
Scheme 1
Reagents and Conditions: (a) BBr3, CH2Cl2, from −78 °C to room temperature, overnight; (b) K2CO3, DMF, 150 °C, overnight.
See this image and copyright information in PMC

References

    1. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. The effect of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976;197:517–532. - PubMed
    1. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW, Taylor DP. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 1992;13:85–86. - PubMed
    1. Colabufo NA, Berardi F, Abate C, Contino M, Niso M, Perrone R. Is the σ2 receptor a histone binding protein? J. Med. Chem. 2006;49:4153–4158. - PubMed
    1. Xu J, Zeng C, Chu W, Pan F, Rothfuss JM, Zhang F, Tu Z, Zhou D, Zeng D, Vangveravong S, Johnston F, Spitzer D, Chang KC, Hotchkiss RS, Hawkins WG, Wheeler KT, Mach RH. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site. Nat. Commun. 2011;2:380. - PMC - PubMed
    1. Abate C, Niso M, Infantino V, Menga A, Berardi F. Elements in support of the ‘non-identity’ of the PGRMC1 protein with the σ2 receptor. Eur. J. Pharmacol. 2015;758:16–23. - PubMed